組織バンク - 世界市場の考察、競合情勢、市場予測（2030年）

世界の組織バンクの市場規模は、2024年～2030年の予測期間にCAGRで5.88%の大幅な成長が見込まれます。組織バンクの需要は、慢性疾患の有病率と罹患率の増加、慢性疾患にかかりやすい老年人口の増加、がん、血液疾患、免疫疾患、遺伝性疾患などの治療可能性によって後押しされています。さらに、臍帯組織と血液の保存に対する社会的認識の変化や、細胞治療における臍帯組織の使用技術の向上、バイオバンクの協調と共同研究の増加、組織バンクにおける先進手法の使用の増加、医療支出の増加などに加え、とりわけ製品開発における技術革新が、2024年～2030年の予測期間における組織バンク市場全体の成長に寄与しています。

組織バンクの市場力学

世界中でのがん、神経疾患、代謝性疾患、糖尿病などの慢性疾患の流行が、組織バンク市場全体を拡大させます。

例えば、GLOBOCAN Statistics 2020によると、2020年に世界中で約1,930万人ががんに罹患し、1,000万人以上ががんで死亡しています。また、同資料によると、がんの罹患率は世界的に急増しており、2040年までに男女ともに新たにがんに罹患する人数が約3,020万人に達すると予測されています。

Macmillan Cancer Support（2022）によると、英国では300万人近くががんと共に生活しており、2025年までに350万人、2030年までに400万人、2040年までに530万人に増加します。

米国疾病予防管理センター（CDC）（2023）によると、米国では2020年に160万3,844人の新規がん患者が報告されました。

GLOBOCAN Statistics 2020によると、2020年、日本では約102万8,658件の新規がん症例が報告されています。

上記のデータから、世界中でのがんの有病率の増加により、組織バンキングの需要が増加すると結論づけることができます。これは、臓器移植の一種である幹細胞移植が、白血病、リンパ腫、多発性骨髄腫、骨髄異形成症候群などの、血液細胞に影響を及ぼすがんの治療でもっとも多く使用されるためです。また、神経芽細胞腫、ユーイング肉腫、再発小児脳腫瘍、胚細胞腫瘍、精巣がんなどにも使用されることがあります。

したがって、上記の要因が2024年～2030年の予測期間に組織バンク市場を推進します。

しかし、組織バンク機関は複雑なシステムであるため高度な技術的専門知識と熟練した人材が必要であることや、組織の供給不足と希少性などが、組織バンク市場全体の成長を抑制する可能性があります。

組織バンク市場のセグメント分析

組織バンク市場の製品セグメントでは、凍結保存機器カテゴリが2023年に大きな収益シェアを獲得する見込みです。これは、このセグメントに関連する利点と用途によるものと考えられます。

凍結保存は組織バンクおよび臓器バンクにおいて重要な役割を果たしています。凍結保存は細胞、組織、臓器の生理的機能を超低温（-80℃または-196℃）で維持し、その時点で細胞活動はほぼ停止します。

細胞や組織の凍結保存は、保存期間にバンクされたサンプルの遺伝的安定性と機能の維持を保証します。また、可能なかぎり最良の患者転帰を保証するために、品質と適合性の評価に貴重な時間を提供します。このような柔軟性は、組織療法の採用の拡大や新しいプロトコルと処置の開発に向けての大きな支えとなります。

さらに、凍結保存された細胞や組織は常に入手可能であるため、新鮮なサンプルを入手する必要がなく、細胞や組織の移植適合性を判定するための広範な品質試験を行うことができます。

したがって、上記の要因により、凍結保存機器カテゴリは大きな成長を記録し、それによって予測期間の組織バンク市場全体の成長を促進します。

当レポートでは、世界の組織バンク市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 組織バンク市場レポートのイントロダクション

第2章 組織バンク市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

第4章 組織バンク市場の主な要因の分析

• 組織バンク市場の促進要因
• 組織バンク市場の抑制要因と課題
• 組織バンク市場の機会

第5章 組織バンク市場のポーターのファイブフォース分析

第6章 組織バンク市場のレイアウト

• 製品別
  • 機器
  • 媒体、消耗品
• 用途別
  • 治療
  • 医学研究
  • その他
• 地域
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第7章 組織バンク市場の企業と製品のプロファイル

• ROKIT HEALTHCARE, INC.
• AMS Biotechnology (Europe) Limited
• Avantor, Inc.
• Sartorius AG
• Azenta US, Inc.
• Bio-Rad Laboratories, Inc
• Eppendorf SE
• Hamilton Company
• Merck KGaA
• Thermo Fisher Scientific Inc.
• LifeLink Tissue Bank
• BioLife Solutions
• ThermoGenesis Holdings, Inc.
• PHC Holdings Corporation
• Taylor-Wharton

第8章 KOLの見解

第9章 プロジェクトアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Tissue Banking Market in Global (2021-2030)
• Table 3: Tissue Banking Market in Global by Product (2021-2030)
• Table 4: Tissue Banking Market in Global by Application (2021-2030)
• Table 5: Tissue Banking Market in Global by Geography (2021-2030)
• Table 6: Tissue Banking Market in North America (2021-2030)
• Table 7: Tissue Banking Market in the US (2021-2030)
• Table 8: Tissue Banking Market in Canada (2021-2030)
• Table 9: Tissue Banking Market in Mexico (2021-2030)
• Table 10: Tissue Banking Market in Europe (2021-2030)
• Table 11: Tissue Banking Market in France (2021-2030)
• Table 12: Tissue Banking Market in Germany (2021-2030)
• Table 13: Tissue Banking Market in the United Kingdom (2021-2030)
• Table 14: Tissue Banking Market in Italy (2021-2030)
• Table 15: Tissue Banking Market in Spain (2021-2030)
• Table 16: Tissue Banking Market in the Rest of Europe (2021-2030)
• Table 17: Tissue Banking Market in Asia-Pacific (2021-2030)
• Table 18: Tissue Banking Market in China (2021-2030)
• Table 19: Tissue Banking Market in Japan (2021-2030)
• Table 20: Tissue Banking Market in India (2021-2030)
• Table 21: Tissue Banking Market in Australia (2021-2030)
• Table 22: Tissue Banking Market in South Korea (2021-2030)
• Table 23: Tissue Banking Market in Rest of Asia-Pacific (2021-2030)
• Table 24: Tissue Banking Market in the Rest of the World (2021-2030)
• Table 25: Tissue Banking Market in the Middle East (2021-2030)
• Table 26: Tissue Banking Market in Africa (2021-2030)
• Table 27: Tissue Banking Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Tissue Banking Market in Global (2021-2030)
• Figure 3: Tissue Banking Market in Global by Product (2021-2030)
• Figure 4: Tissue Banking Market in Global by Application (2021-2030)
• Figure 5: Tissue Banking Market in Global by Geography (2021-2030)
• Figure 6: Tissue Banking Market in North America (2021-2030)
• Figure 7: Tissue Banking Market in the US (2021-2030)
• Figure 8: Tissue Banking Market in Canada (2021-2030)
• Figure 9: Tissue Banking Market in Mexico (2021-2030)
• Figure 10: Tissue Banking Market in Europe (2021-2030)
• Figure 11: Tissue Banking Market in France (2021-2030)
• Figure 12: Tissue Banking Market in Germany (2021-2030)
• Figure 13: Tissue Banking Market in the United Kingdom (2021-2030)
• Figure 14: Tissue Banking Market in Italy (2021-2030)
• Figure 15: Tissue Banking Market in Spain (2021-2030)
• Figure 16: Tissue Banking Market in the Rest of Europe (2021-2030)
• Figure 17: Tissue Banking Market in Asia-Pacific (2021-2030)
• Figure 18: Tissue Banking Market in China (2021-2030)
• Figure 19: Tissue Banking Market in Japan (2021-2030)
• Figure 20: Tissue Banking Market in India (2021-2030)
• Figure 21: Tissue Banking Market in Australia (2021-2030)
• Figure 22: Tissue Banking Market in South Korea (2021-2030)
• Figure 23: Tissue Banking Market in Rest of Asia-Pacific (2021-2030)
• Figure 24: Tissue Banking Market in the Rest of the World (2021-2030)
• Figure 25: Tissue Banking Market in the Middle East (2021-2030)
• Figure 26: Tissue Banking Market in Africa (2021-2030)
• Figure 27: Tissue Banking Market in South America (2021-2030)
• Figure 28: Market Drivers
• Figure 29: Market Barriers
• Figure 30: Marker Opportunities
• Figure 31: PORTER'S Five Force Analysis

Tissue Banking Market By Product (Equipment [Cryopreservation Equipment, Thawing Equipment, Quality Control Equipment, And Others] And Media And Consumables), Application (Therapeutics, Medical Research, And Others), and geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of chronic diseases and increasing use of advanced methodology for tissue banking across the globe

The global tissue banking market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 5.88% during the forecast period from 2024 to 2030. The demand for tissue banking is being boosted by the increasing prevalence and incidence of chronic diseases, the rising aging population prone to chronic diseases, and potential cures for cancers, blood disorders, immune, genetic diseases, and others. Further, the shift in public perception toward cord tissue and blood storage, improving techniques for the use of cord tissues in cellular therapy, increase in the harmonization of biobanks and research collaboration, increasing use of advanced methodology for tissue banking, rising healthcare expenditure, and others, and innovation in product development among others, thereby contribute to the overall growth of the tissue banking market during the forecast period from 2024-2030.

Tissue Banking Market Dynamics:

The increasing prevalence of chronic diseases such as cancers, neurological diseases, metabolic diseases, diabetes, and others across the globe will increase the overall market of tissue banking.

For instance, according to the GLOBOCAN Statistics 2020, in the year 2020, about 19.3 million people were suffering from cancer and more than 10 million people died from cancer, worldwide. The same source reported that the incidence of cancer was growing at a rapid pace in the world and estimated that the number of new cases of cancer in both sexes is projected to reach around 30.2 million by 2040.

As per the Macmillan Cancer Support 2022, nearly 3 million people were living with cancer in the UK, rising to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040.

According to the Centers for Disease Control and Prevention (CDC) 2023, in the United States in 2020, 1,603,844 new cancer cases were reported.

According to the GLOBOCAN Statistics 2020, in 2020 about 1,028,658 new cases of cancer were reported in Japan.

From the above data, it can be concluded that the increasing prevalence of cancers across the globe will increase the demand for tissue banking as stem cell transplants, a type of organ transplantation are most often used to treat people with cancers that affect blood cell, such as leukemia, lymphoma, multiple myeloma, and myelodysplastic syndromes. They may also be used for neuroblastoma, Ewing sarcoma, brain tumors that have come back in children, germ cell tumors, and testicular cancer.

The GODT - Organ Donation and Transplantation Activities 2021 stated that in 2021, there were a total of around 144,302 organ transplants worldwide. The kidney was the most transplanted organ worldwide followed by the liver and the heart. The increasing number of organ transplantations worldwide will increase the demand for tissue banking during the forecast period

Therefore, the above-mentioned factors will propel the tissue banking market during the forecast period from 2024-2030.

However, the need for high technical expertise and skilled personnel as the tissue banking organization is a complex system, insufficiency, and scarcity in tissue availability, and others may restrict the growth of the overall tissue banking market.

Tissue Banking Market Segment Analysis:

Tissue Banking Market by Product (Equipment [Cryopreservation Equipment, Thawing Equipment, Quality Control Equipment, and Others] and Media and consumables), Application (Therapeutics, Medical Research, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the tissue banking market, the cryopreservation equipment category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the advantages and applications associated with the segment.

Cryopreservation plays a significant role in tissue and organ banking. Cryopreservation involves maintaining the physiological function of cells, tissues, and organs at ultra-low temperatures (-80°C or -196°C), at which point cellular activities nearly cease.

Cryopreservation of cells and tissues ensures genetic stability and preserved function of a banked sample throughout storage. It also provides valuable time for quality and suitability assessments to ensure the best possible patient outcomes. This flexibility lends significant support to the increased adoption of tissue therapies and the development of new protocols and procedures.

Further, with the constant availability of cryopreserved cells and tissues, extensive quality testing can be performed to determine the suitability of the cells or tissue for transplantation without the need to obtain fresh samples.

Therefore, owing to the above-mentioned factors, the cryopreservation equipment category is expected to register significant growth, thereby driving the growth of the overall tissue banking market during the forecast period.

North America is expected to dominate the overall Tissue Banking Market:

Among all the regions, North America is estimated to account for the largest share of the Tissue Banking market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of chronic diseases such as cardiovascular disorders, diabetes, cancers, and others, rising burden of aging population prone to chronic ailments, increasing government initiatives, rising demand for transplantation, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about the advantages of organ transplantation, and others, the market for tissue banking is expected to witness prosperity in the region during the forecast period 2024-2030.

The growing prevalence of cardiovascular diseases and other chronic diseases is anticipated to increase market growth. For instance, according to the Centers for Disease Control and Prevention (CDC) 2023, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. The source concluded that about 1 in 20 adults age 20 and older have coronary artery disease (CAD) and every year, about 805,000 people in the United States have a heart attack.

The increasing prevalence of cardiovascular diseases will increase the demand for tissue banking in the country as it can be used to systematically collect, store, and distribute cardiac tissue and other samples for research dedicated to the improved understanding, care, and treatment of individuals with cardiovascular disease.

The Canadian Diabetes Association 2022 report concluded that in 2022 more than 5.7 million Canadians were living with diabetes (type 1 & type 2 diagnosed + type 2 undiagnosed). Moreover, as per the same source, 11.7 million Canadians were living with diabetes or prediabetes.

The increasing prevalence of diabetes will increase the demand for tissue banking in the country as researchers have demonstrated that placenta-derived cells are beneficial for Type 2 diabetes patients due to their angiogenic and immunomodulatory properties.

Additionally, government organizations are heavily investing in various tissue-banking projects, which is further fueling the market growth.

For instance, in October 2021, the National Human Genome Research Institute intended to extend its current gene expression resources to developing tissues by providing USD 38.5 million over five years. The goal of this project is to create a publicly accessible tissue bank and database that will provide fundamental and clinical researchers in the US with data on the expression of human developmental genes in a variety of pediatric tissue types. It is anticipated that these investments will support the region's overall market growth.

Thus, the above-mentioned factors are likely to propel the growth of the tissue banking market in the region during the forecast period from 2024-2030.

Tissue Banking Market Key Players:

Some of the key market players operating in the tissue banking market include ROKIT HEALTHCARE, INC., AMS Biotechnology (Europe) Limited, Avantor, Inc., Sartorius AG, Azenta US, Inc., Bio-Rad Laboratories, Inc., Eppendorf SE, Hamilton Company, Merck KGaA, Thermo Fisher Scientific Inc., LifeLink Tissue Bank, BioLife Solutions, ThermoGenesis Holdings, Inc., PHC Holdings Corporation, Taylor-Wharton, and others.

Recent Developmental Activities in the Tissue Banking Market:

• In November 2022, the Department of Health (DoH), Abu Dhabi, the regulator of the healthcare sector in the United Arab Emirate, and United States-based Eversight, one of the non-profit eye banks in the world, partnered to establish the country's first Eye and Tissue Bank.
• In June 2022, LifeLink Tissue Bank launched the Birth Tissue Donation Program, the first of its kind in the Tampa Bay area, in partnership with Tampa General Hospital (TGH).

Key Takeaways from the Tissue Banking Market Report Study

• Market size analysis for current tissue banking market size (2023), and market forecast for 6 years (2024-2030)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global tissue banking market.
• Various opportunities available for the other competitors in the tissue banking market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current tissue banking market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for tissue banking market growth in the coming future?

Target Audience who can be benefited from this Tissue Banking Market Report Study

• Tissue banking service/product providers
• Research organizations and consulting companies
• Tissue banking-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in tissue banking products and services
• Various End-users who want to know more about the tissue banking market and the latest technological developments in the tissue banking market.

Frequently Asked Questions for the Tissue Banking Market:

1. What is tissue banking?

The procedure of gathering, processing, and conserving transplantable human tissues for possible therapeutic purposes is known as tissue banking. The tissues recovered are used to repair and replace the patients' damaged or missing tissues.

2. What is the market for global tissue banking?

The global tissue banking market is poised for significant growth, projected to achieve a remarkable Compound Annual Growth Rate (CAGR) of 5.88% during the forecast period from 2024 to 2030.

3. What are the drivers for the global tissue banking market?

The demand for tissue banking is being boosted by the shift in public perception toward cord tissue and blood storage, improving techniques for the use of cord tissues in cellular therapy, potential cure for cancers, blood disorders, and immune and genetic diseases, increase in the harmonization of biobanks and research collaboration, increasing prevalence and incidence of chronic diseases, rising aging population prone to chronic diseases, increasing use of advanced methodology for tissue banking, rising healthcare expenditure, and others thereby contributing to the overall growth of the tissue banking market during the forecast period from 2024-2030.

4. Who are the key players operating in the global tissue banking market?

Some of the key market players operating in the tissue banking market include ROKIT HEALTHCARE, INC., AMS Biotechnology (Europe) Limited, Avantor, Inc., Sartorius AG, Azenta US, Inc., Bio-Rad Laboratories, Inc., Eppendorf SE, Hamilton Company, Merck KGaA, Thermo Fisher Scientific Inc., LifeLink Tissue Bank, BioLife Solutions, ThermoGenesis Holdings, Inc., PHC Holdings Corporation, Taylor-Wharton, and others.

5. Which region has the highest share in the tissue banking market?

North America is expected to dominate the overall tissue banking market during the forecast period from 2024-2030. Owing to factors such as the rising prevalence of chronic diseases, the rising burden of the aging population, increasing government initiatives and rising demand for transplantation, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about the advantages of organ transplantation among others, the North America tissue banking market is expected to growth in coming years.

Table of Contents

1. Tissue Banking Market Report Introduction

2. Tissue Banking Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

4. Tissue Banking Market Key Factors Analysis

• 4.1. Tissue Banking Market Drivers
  • 4.1.1. Increasing prevalence of chronic diseases owing to which demand for organ transplantation is surging
  • 4.1.2. Increasing use of advanced methodology for tissue banking
  • 4.1.3. Rising healthcare expenditure
• 4.2. Tissue Banking Market Restraints and Challenges
  • 4.2.1. Need for high technical expertise and skilled personnel as the tissue banking organization is a complex system
  • 4.2.2. Insufficiency and scarcity in tissue availability
• 4.3. Tissue Banking Market Opportunities
  • 4.3.1. Advancements in the medical drug discovery and biopharmaceuticals industry
  • 4.3.2. Increasing awareness about safety aspects in tissue banking

5. Tissue Banking Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. Tissue Banking Market Layout

• 6.1. By Product
  • 6.1.1. Equipment
    • 6.1.1.1. Cryopreservation Equipment
    • 6.1.1.2. Thawing Equipment
    • 6.1.1.3. Quality Control Equipment
    • 6.1.1.4. Others
  • 6.1.2. Media and Consumables
• 6.2. By Application
  • 6.2.1. Therapeutics
  • 6.2.2. Medical Research
  • 6.2.3. Others
• 6.3. By Geography
  • 6.3.1. North America
    • 6.3.1.1. United States Tissue Banking Market Size in USD million (2021-2030)
    • 6.3.1.2. Canada Tissue Banking Market Size in USD million (2021-2030)
    • 6.3.1.3. Mexico Tissue Banking Market Size in USD million (2021-2030)
  • 6.3.2. Europe
    • 6.3.2.1. France Tissue Banking Market Size in USD million (2021-2030)
    • 6.3.2.2. Germany Tissue Banking Market Size in USD million (2021-2030)
    • 6.3.2.3. United Kingdom Tissue Banking Market Size in USD million (2021-2030)
    • 6.3.2.4. Italy Tissue Banking Market Size in USD million (2021-2030)
    • 6.3.2.5. Spain Tissue Banking Market Size in USD million (2021-2030)
    • 6.3.2.6. Rest of Europe Tissue Banking Market Size in USD million (2021-2030)
  • 6.3.3. Asia-Pacific
    • 6.3.3.1. China Tissue Banking Market Size in USD million (2021-2030)
    • 6.3.3.2. Japan Tissue Banking Market Size in USD million (2021-2030)
    • 6.3.3.3. India Tissue Banking Market Size in USD million (2021-2030)
    • 6.3.3.4. Australia Tissue Banking Market Size in USD million (2021-2030)
    • 6.3.3.5. South Korea Tissue Banking Market Size in USD million (2021-2030)
    • 6.3.3.6. Rest of Asia-Pacific Tissue Banking Market Size in USD million (2021-2030)
  • 6.3.4. Rest of the World (RoW)
    • 6.3.4.1. Middle East Tissue Banking Market Size in USD million (2021-2030)
    • 6.3.4.2. Africa Tissue Banking Market Size in USD million (2021-2030)
    • 6.3.4.3. South America Tissue Banking Market Size in USD million (2021-2030)

7. Tissue Banking Market Company and Product Profiles

• 7.1. ROKIT HEALTHCARE, INC.
  • 7.1.1. Company Overview
  • 7.1.2. Company Snapshot
  • 7.1.3. Financial Overview
  • 7.1.4. Product Listing
  • 7.1.5. Entropy
• 7.2. AMS Biotechnology (Europe) Limited
  • 7.2.1. Company Overview
  • 7.2.2. Company Snapshot
  • 7.2.3. Financial Overview
  • 7.2.4. Product Listing
  • 7.2.5. Entropy
• 7.3. Avantor, Inc.
  • 7.3.1. Company Overview
  • 7.3.2. Company Snapshot
  • 7.3.3. Financial Overview
  • 7.3.4. Product Listing
  • 7.3.5. Entropy
• 7.4. Sartorius AG
  • 7.4.1. Company Overview
  • 7.4.2. Company Snapshot
  • 7.4.3. Financial Overview
  • 7.4.4. Product Listing
  • 7.4.5. Entropy
• 7.5. Azenta US, Inc.
  • 7.5.1. Company Overview
  • 7.5.2. Company Snapshot
  • 7.5.3. Financial Overview
  • 7.5.4. Product Listing
  • 7.5.5. Entropy
• 7.6. Bio-Rad Laboratories, Inc
  • 7.6.1. Company Overview
  • 7.6.2. Company Snapshot
  • 7.6.3. Financial Overview
  • 7.6.4. Product Listing
  • 7.6.5. Entropy
• 7.7. Eppendorf SE
  • 7.7.1. Company Overview
  • 7.7.2. Company Snapshot
  • 7.7.3. Financial Overview
  • 7.7.4. Product Listing
  • 7.7.5. Entropy
• 7.8. Hamilton Company
  • 7.8.1. Company Overview
  • 7.8.2. Company Snapshot
  • 7.8.3. Financial Overview
  • 7.8.4. Product Listing
  • 7.8.5. Entropy
• 7.9. Merck KGaA
  • 7.9.1. Company Overview
  • 7.9.2. Company Snapshot
  • 7.9.3. Financial Overview
  • 7.9.4. Product Listing
  • 7.9.5. Entropy
• 7.10. Thermo Fisher Scientific Inc.
  • 7.10.1. Company Overview
  • 7.10.2. Company Snapshot
  • 7.10.3. Financial Overview
  • 7.10.4. Product Listing
  • 7.10.5. Entropy
• 7.11. LifeLink Tissue Bank
  • 7.11.1. Company Overview
  • 7.11.2. Company Snapshot
  • 7.11.3. Financial Overview
  • 7.11.4. Product Listing
  • 7.11.5. Entropy
• 7.12. BioLife Solutions
  • 7.12.1. Company Overview
  • 7.12.2. Company Snapshot
  • 7.12.3. Financial Overview
  • 7.12.4. Product Listing
  • 7.12.5. Entropy
• 7.13. ThermoGenesis Holdings, Inc.
  • 7.13.1. Company Overview
  • 7.13.2. Company Snapshot
  • 7.13.3. Financial Overview
  • 7.13.4. Product Listing
  • 7.13.5. Entropy
• 7.14. PHC Holdings Corporation
  • 7.14.1. Company Overview
  • 7.14.2. Company Snapshot
  • 7.14.3. Financial Overview
  • 7.14.4. Product Listing
  • 7.14.5. Entropy
• 7.15. Taylor-Wharton
  • 7.15.1. Company Overview
  • 7.15.2. Company Snapshot
  • 7.15.3. Financial Overview
  • 7.15.4. Product Listing
  • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us